Trial: 201709055

Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas

Phase

II

Principal Investigator

Johanns, Tanner

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov